Mr. Hinrichs to Become Chair of Audit and Finance Committee
LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V. (NASDAQ:OFIX) announced today that it has
appointed James F. Hinrichs to its Board of Directors, effective
immediately. Mr. Hinrichs joins the Board with more than twenty years'
experience at leading healthcare companies. Effective as of the
Company's 2014 Annual General Meeting of Shareholders scheduled for June
19, 2014, Mr. Hinrichs will become the Chair of the Board's Audit and
Finance Committee and a member of its Nominating and Governance
Committee. The Board has determined that Mr. Hinrichs is independent
under applicable rules of the Nasdaq Stock Market, and qualifies as an
"audit committee financial expert" under applicable rules of the
Securities and Exchange Commission. With his appointment, the Board now
includes five members who have been appointed since March 2013, four of
whom are independent, outside directors.
"Jim's experience as a public company CFO, combined with his knowledge
of the medical device industry and related financial environment, make
him an ideal director for our Board and future Chair of our Audit and
Finance Committee," said Orthofix Chairman Ron Matricaria. "We believe
he will bring added depth to these roles as we work to improve our
reporting processes and realize our full potential."
Mr. Hinrichs has served as the Chief Financial Officer of CareFusion
Corporation since 2010, where he also has responsibility for corporate
development and investor relations activities. He previously served as
CareFusion's Senior Vice President, Global Customer Support, and as its
Senior Vice President, Controller. Prior to joining CareFusion when it
was spun off from Cardinal Health, Inc., he worked for five years at
Cardinal Health in various positions including Executive Vice President
and Corporate Controller of Cardinal Health and as Executive Vice
President and Chief Financial Officer of its Healthcare Supply Chain
Services segment. He joined Cardinal Health following more than a decade
of finance and marketing roles at Merck & Co. He holds undergraduate and
graduate degrees in business from Carnegie Mellon University.
Orthofix International N.V. is a diversified, global medical device
company focused on improving patients' lives by providing superior
reconstructive and regenerative orthopedic and spine solutions to
physicians worldwide. Headquartered in Lewisville, TX, the company has
four strategic business units that include BioStim, Biologics, Extremity
Fixation and Spine Fixation. Orthofix products are widely distributed
via the company's sales representatives, distributors and subsidiaries.
In addition, Orthofix is collaborating on research and development
activities with leading clinical organizations such as the
Musculoskeletal Transplant Foundation, the Orthopedic Research and
Education Foundation and the Texas Scottish Rite Hospital for Children.
For more information, please visit www.orthofix.com.
Orthofix International N.V.
Mark Quick, 214-937-2924
Source: Orthofix International N.V.
News Provided by Acquire Media